Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapi
Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases
3 Stocks to Buy if Biotech Crashes
One Fool highlights three biotech stocks worth considering as biotech stocks drop.
Biotech Stocks: 2 to Avoid, 1 to Buy
Arrowhead Research Corp. and Galena Biopharma are two speculative biotech stocks that investors may want to avoid, while top dog Celgene Corp. still looks like a great pick up. Here's why.
Using a DCF Model to Value Biotech Stocks
Biotech stocks are incredibly difficult to value, but this approach could help make it a bit simpler.
Best Places to Invest in Biotechnology
One Foolish contributor shares his top large- and small-cap biotech stocks for portfolios.